Log in to search using one of your social media accounts:

 

Swiss approve reimbursement for Mallinckrodt treatment

Mallinckrodt PLC said Tuesday that Swiss regulators have approved for reimbursement a treatment for patients who develop certain complications following lung transplants, including the pharmaceutical company's Therakos Cellex photopheresis system. Switzerland's Federal Department of Home Affairs has approved reimbursement of extracorporeal photopheresis (ECP) treatment — during which blood cells are treated outside the body and returned to the bloodstream — for patients there with bronchiolitis…
Source: bizjournals.com Health Care:Biotechnology headlines - Category: Biotechnology Authors: Source Type: news

Related Links:

AbstractIntroductionFlexible fiberoptic bronchoscopy (FFB) plays an important role in the surveillance of cystic fibrosis (CF) patients after lung transplantation (LTx). With rapid onset and clearance, propofol provides a safe and efficient method for sedation during FFB, yet sedation requirements for CF patients are not well described.ObjectivesDue to pharmacokinetic differences for other classes of drugs in CF patients, this study was performed to examine propofol requirements for sedation during bronchoscopy in lung transplant recipients with CF.MethodsA single-center retrospective cohort study was performed to examine ...
Source: Lung - Category: Respiratory Medicine Source Type: research
Claire Wineland vowed she wouldn't have a lung transplant, but her decline from cystic fibrosis made her reconsider. Now she's fighting for a chance at survival.
Source: CNN.com - Health - Category: Consumer Health News Source Type: news
Mycophenolate mofetil (MMF) is commonly prescribed after transplantation and has important advantages over other immunosuppressive drugs but frequent gastrointestinal (GI) side effects limit its use. The mechanism(s) underlying MMF-related GI toxicity have yet to be elucidated.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Original Pre-clinical Science Source Type: research
ConclusionsEarly tracheostomy following lung transplantation decreased both intensive care and hospital stay, due to improved postoperative recovery, even in patients with poor preoperative conditions. Furthermore, length of hospital stay in patients with early tracheostomy was similar to that of patients without tracheostomy after lung transplantation.
Source: General Thoracic and Cardiovascular Surgery - Category: Cardiovascular & Thoracic Surgery Source Type: research
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Source Type: research
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Source Type: research
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Source Type: research
A 67-year-old, non-Hispanic white male underwent bilateral lung transplantation in 2016 for idiopathic pulmonary fibrosis. The patient had good graft function after transplantation, with a peak forced expiratory volume in 1 second of 2.27 liters. Surveillance bronchoscopy and biopsies done at 1, 3, and 6 months post-transplantation did not show any evidence of acute rejection or infection. He was lost to follow-up until 15 months after transplantation, when he presented with 1 week of dyspnea, cough, and fever.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Tags: Case Anecdotes, Comments and Opinions Source Type: research
Ischemia-reperfusion injury, a form of sterile inflammation, is the leading risk factor for both short-term mortality following pulmonary transplantation and chronic lung allograft dysfunction. While it is well recognized that neutrophils are critical mediators of acute lung injury, processes that guide their entry into pulmonary tissue are not well understood. Here, we found that CCR2+ classical monocytes are necessary and sufficient for mediating extravasation of neutrophils into pulmonary tissue during ischemia-reperfusion injury following hilar clamping or lung transplantation. The classical monocytes were mobilized fr...
Source: Journal of Clinical Investigation - Category: Biomedical Science Authors: Source Type: research
Lung transplantation is a well-established treatment for end-stage non-cystic fibrosis bronchiectasis (BR), though information regarding outcomes of transplantation remains limited. Our results of lung transpl...
Source: BMC Pulmonary Medicine - Category: Respiratory Medicine Authors: Tags: Research article Source Type: research
More News: Biotechnology | Health | Health Management | Lung Transplant | Transplants